Health Canada drug identification number

DIN 02409267 — ERIVEDGE 150 MG

ERIVEDGE is a capsule of Vismodegib marketed by HOFFMANN-LA ROCHE LIMITED. The full Vismodegib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02409267
Brand name
ERIVEDGE
Active ingredient
Vismodegib
Strength
150 MG
Dosage form
CAPSULE
Route
ORAL
Manufacturer
HOFFMANN-LA ROCHE LIMITED
Health Canada status
MARKETED
Drug class
Hedgehog pathway inhibitor (antineoplastic agent)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.